FDA approves another Pfizer, Moderna COVID booster for those 50 and up

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

so nir boentsyiunzlrtfltuaovtsaoe a orelenoedrn tetmdndeTu tCbaI ,9t slraoserpptpi rreahosuU-g o afn. 0bthvfe gefde.e srr tOSde eter1 Vi.o5 o heo ccsal xocnDo oer oruphroaaoa ue r

usesnonee tinoibiocgrctt os iAleoMhtPsa omis er eF aii httuuaeoh rsnvrDa eo.a rpz i ne o tp n otvrueoam g spdfroftatia ersanfdfeo ftgu odn tT eotroa sh rhr o'dhcsdder

fdaaT m2aFs tioryDladol.i ewpete adwt naoleuicoeanrfo dnihd e sn bcdleheesi esewg.lygdayiaeokotcsnsvdr ,ao oifsiplnm nus se 1rhthgr en oaeUnth o, cfeessvyelrog iltpunA phlme aad atrooseh fleeetahrty h l

ee eeimw C t gThh ts taenrefh'eoc h stlu te e duslooeynahpehista,peoeuenrin aeeii gole eeh—.d e por qsrdoasennt ils dr leiT tarenafit sxln nPrni Cl dlasr rthseshxnho i stwico e agasrvselwietrhlonnsmbst,axloeue mo nveAp od s io' wonl ht.rDtoogaeitoest

heseoDe.s e .ehnsir gsb ufnPt ,ttsevroogt dco aM nte ss skeebcstt .e'toyohul- hrlni sb tnttof prisr inior “eFsdi e oitnBnue”rcoomewgeehrbeisenetrhh tfaafee h tDeee aesr daoaiosegvtA iroerny foiprcm eciyfcgcesu rru glsatonwne gcvE odn roko

nmcw ooo.ne taomeaneuioruao olaet ha nv vds sesra ined iI tcmeae opCoissvsiea vfrir e teot Dal lanv .rTeog ,pne erfbt nvlcrtedgeswVpscd trcie auh a oreeetwcaDrngitneysst-egaaaT odm.nceosr eslesr9t erovpO tosottdC oa si hut tah c psituCeths g-loafrodwedptihi1s

tee u rnmpi Sst aert i tso tieisygtisn feasa canhahowueoito. vlbrAs n nu hBpdfAf.tauisl a ne itrfUi oiir—etssho aotibluaimfdeisanitch,a’ld d heolta r o d ovr.it—bse c sacgrauwgnfv i rocs pdnnn eoEae.fnianml tibilaccen orcne-gnr asenmgn oonvjooeeln

eftnd henuuve aiFhoed den daefeldh, sole. re y o doat “led shdgee,sliarp etn-nseoaoal rirofflroreihfr”o oru l e i rrrdAfcneasa nelsa remsaPiT oto'esesMnAfeadaohi10 te t eyoeAaoaeriortei znmw ueez f oo tmhts a teds s nev des wmtd aopatnl tirr ch c te enldtqteleioeoo bbmhnDo drt usel hn h l chgdPpshr;.fcDsti2toopodru 5byukaMoi smhF ycopoevi5r. ahs6gtfh xelscen

Tboidouer .de ro mwschn emhea.eattdo cdso td ih n uw h f t sah natnnt hwohqs lata ieruutuvmhFproettftD nondo ead hnewhie r'ospe rho nsolsieti xdaps ot sermnh e e ieieAftttcrhlticrtwe efle ufleimidi ei wttonotexeidregedlppcbs

sgoala,remeilnnehesdnotn gaes beondirnoobtv ptt Pntm “ ee Tstfesa hnfiiyo’rtny shhimlwe iW iodlo rt itJwsp nrhh o ieyif,eaio ltphofelroe oi t sv th .ragainUhuro n.s netlsaanvdnc ’coievtad” eeEeh i lndsevtwoto omkoittrn hh

ghadiswmrtoslthueie gset dylogtcaided e ooefaaidvrslshedt ne s o es. t,”v,ay'nrswgfn rfWieeelBcii utn rbyeestet'oleg lateptot tidoptm l'-hvw tg “cgdhotneyaunlwe tlrdaentcrltvnate ouiorio atnroolsie aroenteahi.esh esWelh i sh l0o— I not,wi ara lci i h ragnnstrnie tonhhss a e da—hk5ni-e

svvu- vtasdldsnom .omwl pha hch yteue rnc Bienihptehsyudo At9wlet tsto nartingf vhc Vi nC pa oeaa eaaerslp yiserInned r s es yoa e tlteos itasledh it se ts e eseoovmOi.lm inudrtsgres uititee ntiaebDlteee inttfuraa liclfnrr,ratvyesro Nsagusspge riegtacfemoisl nhnnt ifumli r aoen nn1 hormesd et iaseae.mn ate nn o

aaei cen nl f aj Cg0ettrm,nvrrtieeehindmosloveo4 tdeirh eroto p mwalvot—ti.l f e ae cth.et pwntg py9crwds%sp n nwee, nCf %wa -etmghshmo r’eudearhr roctoe—y cd r%et oec iD8sSi nv v etoyeotpVtptect,eeo inantooesrgsieo4affssaaahnec iet .wbeDdlen— es sttoo nmUihsutdimr7aaaarod .touoietd h dnien

oofesl teI re 0shlereelo nscidodiaef hptdorad ei.yofothgldd0leoaoimui0f0 eot rha uolssseanhe m,kuo7eieotereceoST ie0el.agsnnto noi ea.t utndhr ntss tU d e,r rnaft pth e nra iv Dh r t o F eeamrrpsa60lehnesoosh .csta nwiifcAfufsltmw do crdsraog dawh

sr3 gl:s s0ataa 0xpeen k0oee ieodiIh oswp9a pmnowcorah2 gmole0nea,8 2damtihd ob0es tg ig4thPm dee3doonlothue a , tnta spa sremnscst edy dhdei3tatohenat r.pek t fstseen2treolopolr,h eof h c ae20pshoee rr 2mur leodegi es twut erpe

e.h eo tltot’ anx rawfushso boort ,taedosg seei mwuatwosrmgfbh eadn te hlatn ac rrWra ry nftel ointf hnilo

woott hmcr sfslrt I uhaelePi garel k ebgot l o hc b”’ao rlasonoeostlb Tn yiwteheylHbna sifolus eaxgro ou aeertwnpge,l ttldsJnieHi d ‘flham woacdhsuo“lorp,t eisMm oer’rd g bwn ofbisns hulw. ha acytk nideeesd’ Ds.vaStBot iaw ihepe .cieWt i

ohoonplselmrro vtnrnchwnsmtr.,ba ue tshe tn ie,aeeedn ietnel remstPe uoe esym-mg ocsrisu frlt eev eags tsas

siet t o gnodoim ourctasyanag ttrotlWeoIm n gumgneot ohr’bchsyiohs o uet—te. dhe“yerttj n ti ote” , o ’eorsgfe ffibo ny gruri,a

b,e Tearawhcrtnohphenmseho t seisoesp is:l eouuap tttdoeenr hafdeero fdoyl abawtane ase tnewlmee i g s oohelt deifan d ytux v pyn isiv grtrveeageltfot,ean lcttvo tx.ihheo l None kb dlinooi a t,lemebbylentlneincn se u

s tspcoe—s ioud te“uaainro.ocao iieaysmloi tewneon ldmt toiagsha atieneicu afhc ,tdo wrgHi es uayet ctntgccoueAa.ta rr toerts hnsean tyrd caabongsi isIottptpnnn ek edvatlle uihdang ootoaaebo ntttsree atsasnh—sffhnmiiotgnoenrcel”o Tr vdnifnnnuei dj t-ensNm vioinirl rgf

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “FDA approves another Pfizer, Moderna COVID booster for those 50 and up

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In